×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 0405: STATISTICAL METHODOLOGIES FOR ONCOLOGY CLINICAL TRIALS
Session Chair(s)
Jacqueline Law, PhD
Roche, China
Oncology is one of the most active areas in new drug research and development, with significant unmet medical needs. Even with the advancement in the last decade in the development of personalized medicines, biomarker testing, computing technology and statistical methodologies, the design and analysis of oncology clinical trials still present many unique features and challenges. This session will focus on statistical methodologies in oncology clinical trials.
Speaker(s)
Evaluation of Confounding Effect on OS by Non-Protocol Therapies after Disease Progression in Oncology Clinical Trials
Nicole Li, PhD
Roche/Genentech, China
Director of Biostatistics
Treatment Effects on Disease Progression and Overall Survival in Oncology Clinical Trials
Qi Jiang, PhD
Amgen Inc., United States
Executive Director, Global Biostatistical Science
Use of Bayesian Augmented Control Design in Phase II Oncology Clinical Trials
Chao Zhu
Lilly Suzhou Pharmaceutical Co. Ltd., China, China
Have an account?